what is the difference between tirzepatide and semaglutide Vs For Weight Loss (2026): Which Works Better? Tirzepatide vs. Retatrutide: Key Differences

Circulation 150(24):19311943

Regulatory alignment: If the FDA eventually considers addiction indications for GLP-1s, clinical documentation, evidence reporting, and reimbursement models will change substantially

In a glycemic control trial evaluating a dose comparable to the 9 mg dose and the 25 mg semaglutide tablet doses in patients with T2D, 1.3% and 1.9% of patients in the 9 mg and 25 mg semaglutide group, respectively, reported moderate-severe non-proliferative diabetic retinopathy events, and 0% and 0.4% reported proliferative retinopathy events, respectively

Rataj-Baniowska, M

Most patients access microdose GLP-1 through compounded formulations , which tend to be more affordable than brand-name products but are not typically covered by insurance

, , , - , 1 3 , (1) 26